In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maxygen Inc.

www.maxygen.com

Latest From Maxygen Inc.

Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus

This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.

Appointments BioPharmaceutical

Spain's Ferrer To Rescue Floundering US Biotech Alexza

US Inhaled CNS drug biotech Alexza looks set to be acquired by Spain’s Ferrer, the licensee of its only marketed product Adasuve outside of the US, in an all-cash offer that includes contingent value rights.

Deals Platform Technologies

Ocera promotes Michael Byrnes to CFO

Ocera Therapeutics, a clinical-stage biopharmaceutical company focused on acute and chronic orphan liver diseases, has promoted Michael Byrnes to chief financial officer. Mr Byrnes has served as vice president, finance at Ocera since June 2014. Prior to joining Ocera, Mr Byrnes held a variety of corporate finance and accounting roles, most recently serving as corporate controller of Maxygen.

Companies

Obituary: biotech entrepreneur Zaffaroni dies aged 91

Alejandro Zaffaroni, the biotechnology entrepreneur and Silicon Valley legend who co-founded a number of firms including Alexza, Affymetrix and Alza, has died aged 91 at his home in Atherton, California. The cause was complications of dementia, his assistant Ana Leech confirmed to the New York Times.

Uruguay
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Maxygen Inc.
  • Senior Management
  • James Sulat, CEO
    Lawrence Briscoe , SVP, CFO
    Elliot Goldstein, MD, COO & CMO
  • Contact Info
  • Maxygen Inc.
    Phone: (650) 298-5300
    301 Galveston Dr.
    Redwood City, CA 94063
    USA
UsernamePublicRestriction

Register